Ani Pharmaceuticals (ANIP) Long-Term Investments (2010 - 2013)
Ani Pharmaceuticals (ANIP) posted Long-Term Investments of $3.4 million for Q1 2013, little changed sequentially from $3.4 million in Q4 2012, and little changed YoY from $3.4 million in Q1 2012.
Ani Pharmaceuticals (ANIP) Long-Term Investments (2010 - 2013) Analysis & Trends
Ani Pharmaceuticals has reported Long-Term Investments for 4 years, with the latest figure at $3.4 million in Q1 2013.
- Quarterly Long-Term Investments changed 0.0% year-over-year to $3.4 million in Q1 2013, while the trailing twelve-month figure through Mar 2013 was $3.4 million (changed 0.0% YoY) and the FY2012 annual result came in at $3.4 million, changed 0.23% from the prior year.
- Long-Term Investments held at $3.4 million in Q1 2013 per ANIP's latest filing, from $3.4 million in the prior quarter.
- Over five years, Long-Term Investments peaked at $3.4 million in Q1 2012 and troughed at $3.4 million in Q4 2010.
- A 4-year average of $3.4 million and a median of $3.4 million in 2012 frame the typical range for Long-Term Investments.
- The sharpest annual moves came in 2011 and 2012: Long-Term Investments changed 0.0% in 2011, then climbed 0.23% in 2012.
- Over 4 years, Long-Term Investments stood at $3.4 million in 2010, then changed by 0.0% to $3.4 million in 2011, then gained by 0.23% to $3.4 million in 2012, then changed by 0.0% to $3.4 million in 2013.
- According to Business Quant data, Long-Term Investments over the past three periods registered $3.4 million, $3.4 million, and $3.4 million for Q1 2013, Q4 2012, and Q3 2012 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | 92.58 Mn |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | 63.23 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 1.14 Bn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | 149.10 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | 60.00 Mn |
| 10 | Ani Pharmaceuticals | 1.63 Bn | 1.27 Bn | 165.89 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2013 | 3.41 Mn |
| Dec 31, 2012 | 3.41 Mn |
| Sep 30, 2012 | 3.41 Mn |
| Jun 30, 2012 | 3.41 Mn |
| Mar 31, 2012 | 3.41 Mn |
| Dec 31, 2011 | 3.41 Mn |
| Sep 30, 2011 | 3.41 Mn |
| Jun 30, 2011 | 3.41 Mn |
| Dec 31, 2010 | 3.41 Mn |